Innate Immunotherapeutics Limited

ASX:IIL ISIN:AU000000IIL6

Innate Immunotherapeutics ASX:IILInnate Immunotherapeutics Limited (ASX:IIL) is a medical biotechnology company with offices in Sydney (Australia) and Auckland (New Zealand). The Company has designed and manufactured a unique immunomodulator microparticle technology. This technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as Multiple Sclerosis. The same technology can be used in the design of better vaccines to potentially treat or prevent diseases such as influenza, cancer, malaria, or tuberculosis.

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12000

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article
###

2,529 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 17) (Since Published: 2529) 

Company Data

    Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.innateimmuno.com